Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases

Parkinsonism and Related Disorders

Volumn 21, Issue 12, 2015, Pages 1435-1440

  Chung, Sun Ju ^a   Kim, Mi Jung ^b   Kim, Juyeon ^a   Ryu, Ho Sung ^a   Kim, Young Jin ^a   Kim, Seong Yoon ^a   Lee, Jae Hong ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Bobath Memorial Hospital   (South Korea)

Author keywords

Alzheimer's disease; Genetic variation; Genome; Parkinson's disease; Type 2 diabetes mellitus

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM CHANNEL KCNQ1; SOMATOMEDIN BINDING PROTEIN 2; TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CDC123 GENE; CDKAL1 GENE; CDKN2B GENE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FTO GENE; GENE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLIS3 GENE; HHEX GENE; HUMAN; IGF2BP2 GENE; KCNJ11 GENE; KCNQ1 GENE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC30A8 GENE; TCF7L2 GENE; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; COGNITION DISORDERS; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; MIDDLE AGED; PSYCHOLOGY; RISK; SOUTH KOREA;

AGED; ALLELES; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK;

EID: 84955735405     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.10.010     Document Type: Article

References (30)

1. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
2. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta. Neuropathol. 1991, 82:239-259.
3. Han W., Li C. Linking type 2 diabetes and Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6557-6558.
4. Santiago J.A., Potashkin J.A. Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends. Mol. Med. 2013, 19:176-186.
5. Yasuda K., Miyake K., Horikawa Y., Hara K., Osawa H., Furuta H., Hirota Y., Mori H., Jonsson A., Sato Y., Yamagata K., Hinokio Y., Wang H.Y., Tanahashi T., Nakamura N., Oka Y., Iwasaki N., Iwamoto Y., Yamada Y., Seino Y., Maegawa H., Kashiwagi A., Takeda J., Maeda E., Shin H.D., Cho Y.M., Park K.S., Lee H.K., Ng M.C., Ma R.C., So W.Y., Chan J.C., Lyssenko V., Tuomi T., Nilsson P., Groop L., Kamatani N., Sekine A., Nakamura Y., Yamamoto K., Yoshida T., Tokunaga K., Itakura M., Makino H., Nanjo K., Kadowaki T., Kasuga M. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 2008, 40:1092-1097.
6. Unoki H., Takahashi A., Kawaguchi T., Hara K., Horikoshi M., Andersen G., Ng D.P., Holmkvist J., Borch-Johnsen K., Jorgensen T., Sandbaek A., Lauritzen T., Hansen T., Nurbaya S., Tsunoda T., Kubo M., Babazono T., Hirose H., Hayashi M., Iwamoto Y., Kashiwagi A., Kaku K., Kawamori R., Tai E.S., Pedersen O., Kamatani N., Kadowaki T., Kikkawa R., Nakamura Y., Maeda S. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in east Asian and European populations. Nat. Genet. 2008, 40:1098-1102.
7. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., Zeggini E., Huth C., Aulchenko Y.S., Thorleifsson G., McCulloch L.J., Ferreira T., Grallert H., Amin N., Wu G., Willer C.J., Raychaudhuri S., McCarroll S.A., Langenberg C., Hofmann O.M., Dupuis J., Qi L., Segre A.V., van Hoek M., Navarro P., Ardlie K., Balkau B., Benediktsson R., Bennett A.J., Blagieva R., Boerwinkle E., Bonnycastle L.L., Bostrom K.Bengtsson, Bravenboer B., Bumpstead S., Burtt N.P., Charpentier G., Chines P.S., Cornelis M., Couper D.J., Crawford G., Doney A.S., Elliott K.S., Elliott A.L., Erdos M.R., Fox C.S., Franklin C.S., Ganser M., Gieger C., Grarup N., Green T., Griffin S., Groves C.J., Guiducci C., Hadjadj S., Hassanali N., Herder C., Isomaa B., Jackson A.U., Johnson P.R., Jorgensen T., Kao W.H., Klopp N., Kong A., Kraft P., Kuusisto J., Lauritzen T., Li M., Lieverse A., Lindgren C.M., Lyssenko V., Marre M., Meitinger T., Midthjell K., Morken M.A., Narisu N., Nilsson P., Owen K.R., Payne F., Perry J.R., Petersen A.K., Platou C., Proenca C., Prokopenko I., Rathmann W., Rayner N.W., Robertson N.R., Rocheleau G., Roden M., Sampson M.J., Saxena R., Shields B.M., Shrader P., Sigurdsson G., Sparso T., Strassburger K., Stringham H.M., Sun Q., Swift A.J., Thorand B., Tichet J., Tuomi T., van Dam R.M., van Haeften T.W., van Herpt T., van Vliet-Ostaptchouk J.V., Walters G.B., Weedon M.N., Wijmenga C., Witteman J., Bergman R.N., Cauchi S., Collins F.S., Gloyn A.L., Gyllensten U., Hansen T., Hide W.A., Hitman G.A., Hofman A., Hunter D.J., Hveem K., Laakso M., Mohlke K.L., Morris A.D., Palmer C.N., Pramstaller P.P., Rudan I., Sijbrands E., Stein L.D., Tuomilehto J., Uitterlinden A., Walker M., Wareham N.J., Watanabe R.M., Abecasis G.R., Boehm B.O., Campbell H., Daly M.J., Hattersley A.T., Hu F.B., Meigs J.B., Pankow J.S., Pedersen O., Wichmann H.E., Barroso I., Florez J.C., Frayling T.M., Groop L., Sladek R., Thorsteinsdottir U., Wilson J.F., Illig T., Froguel P., van Duijn C.M., Stefansson K., Altshuler D., Boehnke M., McCarthy M.I. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589. M. Investigators, G. Consortium.
8. Hara K., Fujita H., Johnson T.A., Yamauchi T., Yasuda K., Horikoshi M., Peng C., Hu C., Ma R.C., Imamura M., Iwata M., Tsunoda T., Morizono T., Shojima N., So W.Y., Leung T.F., Kwan P., Zhang R., Wang J., Yu W., Maegawa H., Hirose H., D.consortium, Kaku K., Ito C., Watada H., Tanaka Y., Tobe K., Kashiwagi A., Kawamori R., Jia W., Chan J.C., Teo Y.Y., Shyong T.E., Kamatani N., Kubo M., Maeda S., Kadowaki T. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum. Mol. Genet. 2014, 23:239-246.
9. Hanson R.L., Muller Y.L., Kobes S., Guo T., Bian L., Ossowski V., Wiedrich K., Sutherland J., Wiedrich C., Mahkee D., Huang K., Abdussamad M., Traurig M., Weil E.J., Nelson R.G., Bennett P.H., Knowler W.C., Bogardus C., Baier L.J. A genome-wide association study in American Indians implicates DNER as a susceptibility locus for type 2 diabetes. Diabetes 2014, 63:369-376.
10. Mahajan A., Go M.J., Zhang W., Below J.E., Gaulton K.J., Ferreira T., Horikoshi M., Johnson A.D., Ng M.C., Prokopenko I., Saleheen D., Wang X., Zeggini E., Abecasis G.R., Adair L.S., Almgren P., Atalay M., Aung T., Baldassarre D., Balkau B., Bao Y., Barnett A.H., Barroso I., Basit A., Been L.F., Beilby J., Bell G.I., Benediktsson R., Bergman R.N., Boehm B.O., Boerwinkle E., Bonnycastle L.L., Burtt N., Cai Q., Campbell H., Carey J., Cauchi S., Caulfield M., Chan J.C., Chang L.C., Chang T.J., Chang Y.C., Charpentier G., Chen C.H., Chen H., Chen Y.T., Chia K.S., Chidambaram M., Chines P.S., Cho N.H., Cho Y.M., Chuang L.M., Collins F.S., Cornelis M.C., Couper D.J., Crenshaw A.T., van Dam R.M., Danesh J., Das D., de Faire U., Dedoussis G., Deloukas P., Dimas A.S., Dina C., Doney A.S., Donnelly P.J., Dorkhan M., van Duijn C., Dupuis J., Edkins S., Elliott P., Emilsson V., Erbel R., Eriksson J.G., Escobedo J., Esko T., Eury E., Florez J.C., Fontanillas P., Forouhi N.G., Forsen T., Fox C., Fraser R.M., Frayling T.M., Froguel P., Frossard P., Gao Y., Gertow K., Gieger C., Gigante B., Grallert H., Grant G.B., Grrop L.C., Groves C.J., Grundberg E., Guiducci C., Hamsten A., Han B.G., Hara K., Hassanali N., Hattersley A.T., Hayward C., Hedman A.K., Herder C., Hofman A., Holmen O.L., Hovingh K., Hreidarsson A.B., Hu C., Hu F.B., Hui J., Humphries S.E., Hunt S.E., Hunter D.J., Hveem K., Hydrie Z.I., Ikegami H., Illig T., Ingelsson E., Islam M., Isomaa B., Jackson A.U., Jafar T., James A., Jia W., Jockel K.H., Jonsson A., Jowett J.B., Kadowaki T., Kang H.M., Kanoni S., Kao W.H., Kathiresan S., Kato N., Katulanda P., Keinanen-Kiukaanniemi K.M., Kelly A.M., Khan H., Khaw K.T., Khor C.C., Kim H.L., Kim S., Kim Y.J., Kinnunen L., Klopp N., Kong A., Korpi-Hyovalti E., Kowlessur S., Kraft P., Kravic J., Kristensen M.M., Krithika S., Kumar A., Kumate J., Kuusisto J., Kwak S.H., Laakso M., Lagou V., Lakka T.A., Langenberg C., Langford C., Lawrence R., Leander K., Lee J.M., Lee N.R., Li M., Li X., Li Y., Liang J., Liju S., Lim W.Y., Lind L., Lindgren C.M., Lindholm E., Liu C.T., Liu J.J., Lobbens S., Long J., Loos R.J., Lu W., Luan J., Lyssenko V., Ma R.C., Maeda S., Magi R., Mannisto S., Matthews D.R., Meigs J.B., Melander O., Metspalu A., Meyer J., Mirza G., Mihailov E., Moebus S., Mohan V., Mohlke K.L., Morris A.D., Muhleisen T.W., Muller-Nurasyid M., Musk B., Nakamura J., Nakashima E., Navarro P., Ng P.K., Nica A.C., Nilsson P.M., Njolstad I., Nothen M.M., Ohnaka K., Ong T.H., Owen K.R., Palmer C.N., Pankow J.S., Park K.S., Parkin M., Pechlivanis S., Pedersen N.L., Peltonen L., Perry J.R., Peters A., Pinidiyapathirage J.M., Platou C.G., Potter S., Price J.F., Qi L., Radha V., Rallidis L., Rasheed A., Rathman W., Rauramaa R., Raychaudhuri S., Rayner N.W., Rees S.D., Rehnberg E., Ripatti S., Robertson N., Roden M., Rossin E.J., Rudan I., Rybin D., Saaristo T.E., Salomaa V., Saltevo J., Samuel M., Sanghera D.K., Saramies J., Scott J., Scott L.J., Scott R.A., Segre A.V., Sehmi J., Sennblad B., Shah N., Shah S., Shera A.S., Shu X.O., Shuldiner A.R., Sigurdsson G., Sijbrands E., Silveira A., Sim X., Sivapalaratnam S., Small K.S., So W.Y., Stancakova A., Stefansson K., Steinbach G., Steinthorsdottir V., Stirrups K., Strawbridge R.J., Stringham H.M., Sun Q., Suo C., Syvanen A.C., Takayanagi R., Takeuchi F., Tay W.T., Teslovich T.M., Thorand B., Thorleifsson G., Thorsteinsdottir U., Tikkanen E., Trakalo J., Tremoli E., Trip M.D., Tsai F.J., Tuomi T., Tuomilehto J., Uitterlinden A.G., Valladares-Salgado A., Vedantam S., Veglia F., Voight B.F., Wang C., Wareham N.J., Wennauer R., Wickremasinghe A.R., Wilsgaard T., Wilson J.F., Wiltshire S., Winckler W., Wong T.Y., Wood A.R., Wu J.Y., Wu Y., Yamamoto K., Yamauchi T., Yang M., Yengo L., Yokota M., Young R., Zabaneh D., Zhang F., Zhang R., Zheng W., Zimmet P.Z., Altshuler D., Bowden D.W., Cho Y.S., Cox N.J., Cruz M., Hanis C.L., Kooner J., Lee J.Y., Seielstad M., Teo Y.Y., Boehnke M., Parra E.J., Chambers J.C., Tai E.S., McCarthy M.I., Morris A.P. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 2014, 46:234-244. D.I.G. Replication, C. Meta-analysis, C. Asian Genetic Epidemiology Network Type 2 Diabetes, C. South Asian Type 2 Diabetes, C. Mexican American Type 2 Diabetes, C. Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples.
11. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 1988, 51:745-752.
12. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984, 34:939-944.
13. International HapMap Consortium A haplotype map of the human genome. Nature 2005, 437:1299-1320.
14. Kroner Z. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?. Altern. Med. Rev. 2009, 14:373-379.
15. Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int. J. Neurosci. 1993, 69:125-130.
16. Schernhammer E., Hansen J., Rugbjerg K., Wermuth L., Ritz B. Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes. Care 2011, 34:1102-1108.
17. de la Monte S.M. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease. Drugs 2012, 72:49-66.
18. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
19. Chen H., O'Reilly E.J., Schwarzschild M.A., Ascherio A. Peripheral inflammatory biomarkers and risk of Parkinson's disease. Am. J. Epidemiol. 2008, 167:90-95.
20. Heneka M.T., Carson M.J., Khoury J.E., Landreth G.E., Brosseron F., Feinstein D.L., Jacobs A.H., Wyss-Coray T., Vitorica J., Ransohoff R.M., Herrup K., Frautschy S.A., Finsen B., Brown G.C., Verkhratsky A., Yamanaka K., Koistinaho J., Latz E., Halle A., Petzold G.C., Town T., Morgan D., Shinohara M.L., Perry V.H., Holmes C., Bazan N.G., Brooks D.J., Hunot S., Joseph B., Deigendesch N., Garaschuk O., Boddeke E., Dinarello C.A., Breitner J.C., Cole G.M., Golenbock D.T., Kummer M.P. Neuroinflammation in Alzheimer's disease. Lancet. Neurol. 2015, 14:388-405.
21. Picone P., Nuzzo D., Caruana L., Scafidi V., Di Carlo M. Mitochondrial dysfunction: different routes to Alzheimer's disease therapy. Oxid. Med. Cell. Longev. 2014, 2014:780179.
22. Rosales-Corral S., Tan D.X., Manchester L., Reiter R.J., Diabetes, Disease Alzheimer Two overlapping pathologies with the same background: oxidative stress. Oxid. Med. Cell. Longev. 2015, 2015:985845.
23. Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 1996, 384:78-80.
24. Demolombe S., Franco D., de Boer P., Kuperschmidt S., Roden D., Pereon Y., Jarry A., Moorman A.F., Escande D. Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. Am. J. Physiol. Cell. Physiol. 2001, 280:C359-C372.
25. Damcott C.M., Pollin T.I., Reinhart L.J., Ott S.H., Shen H., Silver K.D., Mitchell B.D., Shuldiner A.R. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006, 55:2654-2659.
26. Proitsi P., Lupton M.K., Velayudhan L., Hunter G., Newhouse S., Lin K., Fogh I., Tsolaki M., Daniilidou M., Pritchard M., Craig D., Todd S., Johnston J.A., McGuinness B., Kloszewska I., Soininen H., Mecocci P., Vellas B., Passmore P.A., Sims R., Williams J., Brayne C., Stewart R., Sham P., Lovestone S., Powell J.F. Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease. Neurobiol. Aging 2014, 35. I. Alzheimer's Disease Neuroimaging, G. Consortium, 2883 e2883-2883 e2810.
27. Bohnen N.I., Kotagal V., Muller M.L., Koeppe R.A., Scott P.J., Albin R.L., Frey K.A., Petrou M. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Park. Relat. Disord. 2014, 20:1394-1398.
28. Matsuzaki T., Sasaki K., Tanizaki Y., Hata J., Fujimi K., Matsui Y., Sekita A., Suzuki S.O., Kanba S., Kiyohara Y., Iwaki T. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 2010, 75:764-770.
29. Thambisetty M., Jeffrey Metter E., Yang A., Dolan H., Marano C., Zonderman A.B., Troncoso J.C., Zhou Y., Wong D.F., Ferrucci L., Egan J., Resnick S.M., O'Brien R.J. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the baltimore longitudinal study of aging. JAMA. Neurol. 2013, 70:1167-1172.
30. Rawlings A.M., Sharrett A.R., Schneider A.L., Coresh J., Albert M., Couper D., Griswold M., Gottesman R.F., Wagenknecht L.E., Windham B.G., Selvin E. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann. Intern. Med. 2014, 161:785-793.